Evidence map›Paper›PMID 33864640›Full record

ArticleRisk analysis : an official publication of the Society for Risk Analysis2021

Assessing the Outbreak Risk of Epidemics Using Fuzzy Evidential Reasoning.

Xianliang Shi, Jiangning Li, Anqiang Huang, Shaohua Song, Zaili Yang

Abstract read
In one paragraph

Article in Risk analysis : an official publication of the Society for Risk Analysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xianliang ShiSchool of Economics and Management, Beijing Jiaotong University, Beijing, China.
Jiangning LiSchool of Economics and Management, Beijing Jiaotong University, Beijing, China.
Anqiang HuangSchool of Economics and Management, Beijing Jiaotong University, Beijing, China.
Shaohua SongSchool of Economics and Management, Beijing Jiaotong University, Beijing, China.
Zaili YangSchool of Maritime and Mechancial Engineering, John Moores Liverpool University, Liverpool, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidemic diseases (EDs) present a significant but challenging risk endangering public health, evidenced by the outbreak of COVID-19. Compared to other risks affecting public health such as flooding, EDs attract little attention in terms of risk assessment in the current literature. It does not well respond to the high practical demand for advanced techniques capable of tackling ED risks. To bridge this gap, an adapted fuzzy evidence reasoning method is proposed to realize the quantitative analysis of ED outbreak risk assessment (EDRA) with high uncertainty in risk data. The novelty of this article lies in (1) taking the lead to establish the outbreak risk evaluation system of epidemics covering the whole epidemic developing process, (2) combining quantitative and qualitative analysis in the fields of epidemic risk evaluation, (3) collecting substantial first-hand data by reviewing transaction data and interviewing the frontier experts and policymakers from Chinese Centers for Disease Control and Chinese National Medical Products Administration. This work provides useful insights for the regulatory bodies to (1) understand the risk levels of different EDs in a quantitative manner and (2) the sensitivity of different EDs to the identified risk factors for their effective control. For instance, in the case study, we use real data to disclose that influenza has the highest breakout risk level in Beijing. The proposed method also provides a potential tool for evaluating the outbreak risk of COVID-19.

Indexed as

Disease OutbreaksFuzzy LogicPublic Health AdministrationAdultChinaCOVID-19EpidemicsHumansMaleMiddle AgedPrincipal Component AnalysisPublic HealthRisk AssessmentRisk FactorsSARS-CoV-2Sensitivity and SpecificityEpidemic diseasesevidential reasoningrisk assessment

Identifiers

PMID33864640
PMCPMC8251401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.